Identification of a novel mutation of the SHOX gene in a patient with Leri-Weill dyschondrosteosis accompanied by growth hormone deficiency
- PMID: 38956755
- PMCID: PMC11220397
- DOI: 10.6065/apem.2346236.118
Identification of a novel mutation of the SHOX gene in a patient with Leri-Weill dyschondrosteosis accompanied by growth hormone deficiency
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures


References
-
- Binder G. Short stature due to SHOX deficiency: genotype, phenotype, and therapy. Horm Res Paediatr. 2011;75:81–9. - PubMed
-
- Blaschke RJ, Rappold GA. SHOX: growth, Leri-Weill and Turner syndromes. Trends Endocrinol Metab. 2000;11:227–30. - PubMed
-
- Heath K. Leri-Weill dyschondrosteosis [Internet]. Quincy (MA): National Organization for Rare Disorders (NORD); 2020 [cited 2023 Jul 10]. Available from: https://rarediseases.org/rare-diseases/leriweilldyschondrosteosis/
-
- Blum WF, Ross JL, Zimmermann AG, Quigley CA, Child CJ, Kalifa G, et al. GH treatment to final height produces similar height gains in patients with SHOX deficiency and Turner syndrome: results of a multicenter trial. J Clin Endocrinol Metab. 2013;98:E1383–92. - PubMed
-
- Scalco RC, Melo SS, Pugliese-Pires PN, Funari MF, Nishi MY, Arnhold IJ, et al. Effectiveness of the combined recombinant human growth hormone and gonadotropinreleasing hormone analog therapy in pubertal patients with short stature due to SHOX deficiency. J Clin Endocrinol Metab. 2010;95:328–32. - PMC - PubMed
LinkOut - more resources
Full Text Sources